Charing Cross Hospital

Chelsea, London W6 8RF

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Non-Small Cell Lung Cancer

Studies at this site

• A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY) — Running, not enrolling